These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22240760

  • 1. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
    Yoon JW, Cho BJ, Park HS, Kang SM, Choi SH, Jang HC, Shin H, Lee MJ, Kim YB, Park KS, Lim S.
    Int J Cardiol; 2013 Jul 15; 167(1):126-33. PubMed ID: 22240760
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
    Lim S, Lee GY, Park HS, Lee DH, Tae Jung O, Kyoung Min K, Kim YB, Jun HS, Hak Chul J, Park KS.
    Cardiovasc Res; 2017 Feb 15; 113(2):183-194. PubMed ID: 27702762
    [Abstract] [Full Text] [Related]

  • 3. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions.
    Cheng M, Li X, Guo Z, Cui X, Li H, Jin C, Zhang X, Guan X.
    J Cardiovasc Pharmacol; 2013 Oct 15; 62(4):361-8. PubMed ID: 23792702
    [Abstract] [Full Text] [Related]

  • 4. Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats.
    Zhang YQ, Tian F, Zhou Y, Chen YD, Li B, Ma Q, Zhang Y.
    Cardiovasc Diabetol; 2016 Apr 08; 15():62. PubMed ID: 27059601
    [Abstract] [Full Text] [Related]

  • 5. Exogenous SERP1 attenuates restenosis by restoring GLP-1 receptor activity in diabetic rats following vascular injury.
    Feng L, Wang J, Ma X.
    Biomed Pharmacother; 2018 Jul 08; 103():290-300. PubMed ID: 29656185
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
    Ouyang P, Peng LS, Yang H, Peng WL, Wu WY, Xu AL.
    Sheng Li Xue Bao; 2003 Apr 25; 55(2):128-34. PubMed ID: 12715099
    [Abstract] [Full Text] [Related]

  • 7. The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.
    Roubille F, Busseuil D, Shi Y, Nachar W, Mihalache-Avram T, Mecteau M, Gillis MA, Brand G, Théberge-Julien G, Brodeur MR, Kernaleguen AE, Gombos M, Rhéaume E, Tardif JC.
    Atherosclerosis; 2014 Oct 25; 236(2):277-85. PubMed ID: 25108619
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M, Morishita R, Hayashi S, Jo N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.
    Diabetologia; 2001 Aug 25; 44(8):1034-42. PubMed ID: 11484082
    [Abstract] [Full Text] [Related]

  • 9. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
    Takigawa T, Tsurushima H, Suzuki K, Tsuruta W, Nakamura K, Matsumura A.
    J Vasc Surg; 2012 Feb 25; 55(2):506-16. PubMed ID: 22264805
    [Abstract] [Full Text] [Related]

  • 10. Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats.
    Lim S, Choi SH, Shin H, Cho BJ, Park HS, Ahn BY, Kang SM, Yoon JW, Jang HC, Kim YB, Park KS.
    PLoS One; 2012 Feb 25; 7(4):e35007. PubMed ID: 22493727
    [Abstract] [Full Text] [Related]

  • 11. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
    Hirschberg K, Tarcea V, Páli S, Barnucz E, Gwanmesia PN, Korkmaz S, Radovits T, Loganathan S, Merkely B, Karck M, Szabó G.
    Int J Cardiol; 2013 Jul 31; 167(2):470-7. PubMed ID: 22357420
    [Abstract] [Full Text] [Related]

  • 12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J, Leppänen O, Braesen JH, Schunck WH, Mueller D, Jung F, Mrowietz C, Jastroch M, von Bergwelt-Baildon M, Kappert K, Heuser A, Drenckhahn JD, Pieske B, Thierfelder L, Ylä-Herttuala S, Blaschke F.
    Arterioscler Thromb Vasc Biol; 2016 Aug 31; 36(8):1534-48. PubMed ID: 27283742
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
    Eriksson L, Saxelin R, Röhl S, Roy J, Caidahl K, Nyström T, Hedin U, Razuvaev A.
    J Vasc Res; 2015 Aug 31; 52(1):41-52. PubMed ID: 25966620
    [Abstract] [Full Text] [Related]

  • 14. Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway.
    Jiang A, Liu L, Wang J, Liu Y, Deng S, Jiang T.
    Cardiovasc Toxicol; 2024 Jun 31; 24(6):587-597. PubMed ID: 38691303
    [Abstract] [Full Text] [Related]

  • 15. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I, de Vries H, Korporaal SJ, Foks AC, Bot M, van Veldhoven J, Ter Borg MN, van Santbrink PJ, van Berkel TJ, Kuiper J, Ijzerman AP.
    Arterioscler Thromb Vasc Biol; 2012 Sep 31; 32(9):2197-205. PubMed ID: 22743060
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival.
    Ekstrand J, Razuvaev A, Folkersen L, Roy J, Hedin U.
    J Vasc Surg; 2010 Jul 31; 52(1):167-75. PubMed ID: 20537494
    [Abstract] [Full Text] [Related]

  • 17. Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of Notch pathway.
    Zhang J, Chen J, Xu C, Yang J, Guo Q, Hu Q, Jiang H.
    J Cardiovasc Pharmacol; 2014 Mar 31; 63(3):233-9. PubMed ID: 24603118
    [Abstract] [Full Text] [Related]

  • 18. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A, Henderson B, Girnita L, Larsson O, Axelson M, Hedin U, Roy J.
    J Vasc Surg; 2007 Jul 31; 46(1):108-15. PubMed ID: 17606126
    [Abstract] [Full Text] [Related]

  • 19. Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.
    Kong BS, Im SJ, Lee YJ, Cho YH, Do YR, Byun JW, Ku CR, Lee EJ.
    PLoS One; 2016 Jul 31; 11(3):e0149394. PubMed ID: 27002821
    [Abstract] [Full Text] [Related]

  • 20. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B, Milz S, Vogeser M, Michaelis C, Vorpahl M, Schömig A, Kastrati A, Wessely R.
    FASEB J; 2004 Aug 31; 18(11):1285-7. PubMed ID: 15180955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.